The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
And given how much variability there is in men with androgen receptor density, we I I think we have a pretty clear sense that in men levels don't tell you much unless you're below, you know, 350, 400. You know, if you're below that level, you're really going to be hypogonatal. Um, but men can be replete at 600 and other men might not be replete till they're at a,000. And again, it just comes down to AR density.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.